Skip to content

Comparison of Haemostatic Effects of Tranexamic Acid, Baricitinib and Baricitinib Sequential with Tranexamic Acid in Posterior Scoliosis Correction and Fusion Surgery for Adolescent Idiopathic Scoliosis: A Prospective, Double-Blind, Randomised Controlled Clinical Study

Comparison of Haemostatic Effects of Tranexamic Acid, Baricitinib and Baricitinib Sequential with Tranexamic Acid in Posterior Scoliosis Correction and Fusion Surgery for Adolescent Idiopathic Scoliosis: A Prospective, Double-Blind, Randomised Controlled Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124654
Enrollment
Unknown
Registered
2026-05-14
Start date
2026-05-18
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent idiopathic scliosis

Interventions

Tranexamic acid group:On the evening prior to surgery at 22:30, administer 2 ml of normal saline by intramuscular injection. Fifteen minutes before skin incision, administer 50 mg/kg of TXA intravenou
Bachu Ting Group:On the evening prior to surgery at 22:30, administer 1 U of barbiturate (powder formulation, 1 U/vial) + 2 ml saline solution via intramuscular injection. Fifteen minutes before skin

Sponsors

West China Tianfu Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 10 and 18 years diagnosed with AIS who underwent PSS surgery; 2. Patients and their families consented to participate in this study and signed the relevant informed consent forms.

Exclusion criteria

Exclusion criteria: 1. Patients with severe underlying cardiovascular or cerebrovascular conditions unsuitable for surgery; 2. Patients with severe anaemia or coagulation disorders prior to surgery; 3. Individuals with allergies to TXA or bartitin; 4. Patients with severe hepatic or renal insufficiency; 5. Those with a history of thrombosis; 6. Patients still taking anticoagulants (such as aspirin) within two weeks prior to surgery; 7. Intraoperative dura mater injury resulting in cerebrospinal fluid leakage.

Design outcomes

Primary

MeasureTime frame
TBL on the first, second and third days post-surgery;Postoperative blood transfusion rate;

Secondary

MeasureTime frame
Intraoperative blood loss;Occult blood loss;Postoperative fibrinolysis and inflammatory markers;Total postoperative drainage volume;Postoperative hospital stay duration;Postoperative complications;

Countries

China

Contacts

Public ContactLiu Li

West China Tianfu Hospital, Sichuan University

liuli_guke@163.com+86 180 3054 8634

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026